大血管急性缺血性卒中治疗后随访MR成像的侧支循环状态生物标志物与短期结局相关
该回顾性研究纳入273例前循环大血管闭塞急性缺血性卒中患者,分析治疗后随访MRI的FLAIR高信号血管征(FHV,用NIH-FHV评分NFS量化)和SWI刷状征(SBS)与临床结局的关系。结果显示NFS与NIHSS改善≥4分呈负相关(ρ=-0.27),与再灌注分级mTICI呈负相关(ρ=-0.32),并独立关联较差的NIHSS改善(OR 0.64)和较低的出血转化风险(OR 0.76);在181例成功再灌注(mTICI≥2b)亚组中NFS仍可预测较差的NIHSS改善(OR 0.57)。SBS单独与结局无独立关联。
要点
- 治疗后MRI的NIH-FHV评分(NFS)与较差的早期神经功能改善独立相关(OR 0.64),且与较低的出血转化风险独立相关(OR 0.76)。
- 在成功再灌注(mTICI≥2b)亚组中,NFS仍可预测较差的NIHSS改善(OR 0.57),20%的mTICI 3级患者仍可见FHV。
- SWI刷状征(SBS)单独与结局无独立关联,可能仅反映辅助性侧支循环动态。
核心结论
- 治疗后MRI的NFS是持续性灌注缺损和早期神经功能结局的稳健影像生物标志物,即使成功再灌注后仍具预测价值;SBS单独预后效用有限。
研究设计与样本
- 回顾性分析273例前循环大血管闭塞急性缺血性卒中(AIS-LVO)患者,均有院内随访MRI;评估NFS和SBS并与NIHSS变化(≥4分改善)和出血转化相关分析;采用Spearman相关和logistic回归校正临床协变量;在181例成功再灌注(mTICI≥2b)亚组中重复分析。
关键影像表现/征象
- 治疗后38%的患者可见FLAIR高信号血管征(FHV),20%可见SWI刷状征(SBS)。
- NFS与SBS呈正相关(ρ=0.54,P<.01)。
- 在成功再灌注亚组中,20%的mTICI 3级病例仍显示FHV。
诊断标准与关键数值
- NFS与NIHSS改善(≥4分)呈负相关(ρ=-0.27,P<.01),与再灌注分级mTICI呈负相关(ρ=-0.32,P<.01)。
- NFS独立关联较差的NIHSS改善(OR 0.64,P<.01)和降低的出血转化风险(OR 0.76,P<.01)。
- 成功再灌注亚组中,NFS仍预测较差的NIHSS改善(OR 0.57,P=.01)。
- SBS单独与结局无独立关联。
临床应用与阅片要点
- 治疗后随访MRI可评估NFS以提示持续性灌注缺损和早期神经功能结局,即使在成功再灌注(mTICI≥2b)后仍具预测价值。
- NFS与较低的出血转化风险独立相关(OR 0.76),阅片时需结合再灌注状态综合解读。
- SBS可能反映辅助性侧支循环动态,但单独预后效用有限,不宜单独作为结局预测指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: FLAIR hyperintense vessels (FHV), quantified using the National Institutes of Health (NIH)-FHV score (NFS), and the SWI brush sign (SBS) are MRI markers associated with hemodynamic impairment in acute ischemic stroke (AIS). We aimed to evaluate the prognostic significance of posttreatment NFS and SBS in patients with anterior circulation large-vessel occlusion (AIS-LVO), including those with successful reperfusion.
MATERIALS AND METHODS: We retrospectively analyzed 273 patents with AIS-LVO with in-hospital follow-up MRI. NFS and SBS were evaluated and correlated with clinical outcomes including NIHSS shift (≥4-point improvement) and hemorrhagic transformation (HT). The Spearman correlation and logistic regression were performed, adjusting for clinical covariates. Analyses were repeated in the successfully reperfused subgroup of 181 cases (modified TICI [mTICI] ≥2b).
RESULTS: FHV and the SBS were observed posttreatment in 38% and 20% of patients, respectively. NFS and SBS were positively correlated (ρ = 0.54, P < .01). NFS inversely correlated with NIHSS shift (ρ = -0.27, P < .01) and reperfusion grade (mTICI; ρ = -0.32, P < .01). NFS was independently associated with worse NIHSS shift (OR, 0.64; P < .01) and reduced odds of HT (OR, 0.76; P < .01). Among patients with successful reperfusion, 20% of mTICI 3 cases showed FHV. In this subgroup, NFS remained predictive of poor NIHSS shift (OR, 0.57; P = .01). SBS alone was not independently associated with outcomes.
CONCLUSIONS: NFS on posttreatment MRI is a robust imaging biomarker of persistent perfusion deficits and early neurologic outcome, even after successful reperfusion. SBS may reflect complementary collateral dynamics but showed limited independent prognostic utility.
引用
- Greene C, Cho A, Salim HA, et al. Posttreatment Follow-Up MR Imaging Biomarkers of Collateral Status Are Associated with Short-Term Outcomes in Large-Vessel Acute Ischemic Stroke. AJNR Am J Neuroradiol. 2026. PMID: 41781179. doi:10.3174/ajnr.A9035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。